Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay
- PMID: 23722435
- DOI: 10.1099/jmm.0.062000-0
Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay
Abstract
Recent vaccination with pertussis vaccine can confound serological and oral fluid (OF) assays targeting anti-pertussis toxin (anti-PT) IgG antibodies as a marker of recent infection. This study sought to establish the minimum potentially confounding time period based on experimental data to assist interpretation from such samples submitted from UK subjects for pertussis diagnosis. Anti-PT IgG antibody response and decay were measured post-vaccination using a modified OF IgG antibody-capture ELISA (GACELISA). Data were obtained from 72 infants after the third acellular pertussis vaccine dose in the primary schedule (4 months of age) and from 119 children after the single dose at preschool age (3 years 4 months to 5 years 8 months of age). Specimens were taken at approximately 1 month intervals for 9 months post-primary immunization (third dose) and 13 months post-preschool booster (PSB). The modified GACELISA demonstrated a sensitivity of 52/56 (92.9 %: 95 % CI 82.7-98.0) and a specificity of 120/128 (93.8 %: 95 % CI 88.0-97.3) and showed good agreement with the National Reference Laboratory standard anti-PT IgG serum ELISA (rank correlation = 0.80) and the original OF assay (rank correlation = 0.79). Modelling of the decline in antibody titres showed a reduction of 54 % and 34 % for each doubling of time after day 14 for the post-third primary dose and post-PSB subjects, respectively. These data suggest that the minimum confounding time period is approximately 300 days for samples obtained post-primary immunization and at least 3 years for samples submitted from UK children following immunization with the PSB. These data will greatly assist the interpretation of single high diagnostic anti-PT IgG titres by allowing an estimate of the positive predictive value, when the number of days post-immunization and prevalence are known or assumed.
Similar articles
-
Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.Vaccine. 2012 Nov 6;30(48):6897-902. doi: 10.1016/j.vaccine.2012.09.003. Epub 2012 Sep 13. Vaccine. 2012. PMID: 22981763
-
Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.J Med Microbiol. 2010 Sep;59(Pt 9):1029-1036. doi: 10.1099/jmm.0.020826-0. Epub 2010 May 27. J Med Microbiol. 2010. PMID: 20508003
-
Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.Infect Dis (Lond). 2017 Aug;49(8):594-600. doi: 10.1080/23744235.2017.1306101. Epub 2017 Mar 23. Infect Dis (Lond). 2017. PMID: 28335677
-
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.Vaccine. 2013 Oct 25;31(45):5178-91. doi: 10.1016/j.vaccine.2013.08.034. Epub 2013 Aug 28. Vaccine. 2013. PMID: 23994021 Review.
-
Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.Toxins (Basel). 2021 Jul 21;13(8):508. doi: 10.3390/toxins13080508. Toxins (Basel). 2021. PMID: 34437379 Free PMC article. Review.
Cited by
-
Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis.Sci Rep. 2017 Jan 16;7:40328. doi: 10.1038/srep40328. Sci Rep. 2017. PMID: 28091579 Free PMC article.
-
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction.Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236-S243. doi: 10.1093/cid/ciw559. Clin Infect Dis. 2016. PMID: 27838678 Free PMC article.
-
The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections.PLoS One. 2016 Feb 5;11(2):e0148507. doi: 10.1371/journal.pone.0148507. eCollection 2016. PLoS One. 2016. PMID: 26848833 Free PMC article.
-
Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort study.BMJ. 2014 Jun 24;348:g3668. doi: 10.1136/bmj.g3668. BMJ. 2014. PMID: 24961836 Free PMC article.
-
Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019.Euro Surveill. 2021 Mar;26(12):2000244. doi: 10.2807/1560-7917.ES.2021.26.12.2000244. Euro Surveill. 2021. PMID: 33769247 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials